$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000162828020014684 Filed on October 22, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$1.810M	$2.036M	$2.088M
YoY Change	5.85%	-2.48%	-43.06%
Cost Of Revenue	$480.0K	$537.6K	$914.3K
YoY Change	-25.0%	-41.2%	-49.79%
Gross Profit	$1.330M	$1.499M	$1.174M
YoY Change	25.47%	27.69%	-36.41%
Gross Profit Margin	73.48%	73.6%	56.21%
Selling, General & Admin	$1.120M	$1.104M	$2.111M
YoY Change	-38.46%	-47.7%	-36.99%
% of Gross Profit	84.21%	73.66%	179.83%
Research & Development	$540.0K	$652.7K	$475.1K
YoY Change	-14.29%	37.36%	-59.68%
% of Gross Profit	40.6%	43.55%	40.48%
Depreciation & Amortization	$20.00K	$20.00K	-$10.00K
YoY Change	0.0%	-300.0%	-133.33%
% of Gross Profit	1.5%	1.33%	-0.85%
Operating Expenses	$1.660M	$1.757M	$2.586M
YoY Change	-32.52%	-32.07%	-42.9%
Operating Profit	-$330.0K	-$257.9K	-$1.412M
YoY Change	-76.43%	-81.74%	-47.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$774.00	$7.464K
YoY Change		-89.63%	-62.68%
Pretax Income	-$330.0K	-$260.0K	-$1.400M
YoY Change	-68.87%	-81.43%	-228.44%
Income Tax
% Of Pretax Income
Net Earnings	-$330.0K	-$257.1K	-$1.405M
YoY Change	-68.87%	-81.69%	-229.33%
Net Earnings / Revenue	-18.23%	-12.63%	-67.27%
Basic Earnings Per Share		-$0.07	-$0.14
Diluted Earnings Per Share	-$87.07K	-$0.07	-$0.14
COMMON SHARES
Basic Shares Outstanding	3.785M shares	3.785M shares	978.2K shares
Diluted Shares Outstanding		3.785M shares	978.2K shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.230M	$4.930M	$3.190M
YoY Change	67.09%	54.55%	-57.64%
Cash & Equivalents	$5.226M	$4.929M	$3.187M
Short-Term Investments
Other Short-Term Assets	$480.0K	$680.0K	$670.0K
YoY Change	-26.15%	1.49%	-19.28%
Inventory	$1.051M	$1.050M	$1.079M
Prepaid Expenses
Receivables	$334.3K	$633.1K	$524.0K
Other Receivables	$0.00	$0.00	$1.180M
Total Short-Term Assets	$7.090M	$7.290M	$6.636M
YoY Change	30.55%	9.86%	-47.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.5K	$205.7K	$299.3K
YoY Change	-32.9%	-31.28%	-21.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$28.52K	$30.00K	$30.00K
YoY Change	-4.92%	0.0%	-66.67%
Total Long-Term Assets	$904.7K	$1.050M	$1.871M
YoY Change	-38.16%	-43.88%	300.86%
TOTAL ASSETS
Total Short-Term Assets	$7.090M	$7.290M	$6.636M
Total Long-Term Assets	$904.7K	$1.050M	$1.871M
Total Assets	$7.995M	$8.340M	$8.507M
YoY Change	15.97%	-1.96%	-34.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$142.3K	$192.4K	$638.5K
YoY Change	-80.39%	-69.88%	-44.53%
Accrued Expenses	$998.4K	$1.011M	$2.613M
YoY Change	-30.84%	-61.3%	35.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.285M	$2.386M	$3.915M
YoY Change	-33.69%	-39.04%	-6.31%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$460.0K	$580.0K	$1.020M
YoY Change	-50.0%	-43.14%
Total Long-Term Liabilities	$460.0K	$580.0K	$1.020M
YoY Change	-50.0%	-43.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.285M	$2.386M	$3.915M
Total Long-Term Liabilities	$460.0K	$580.0K	$1.020M
Total Liabilities	$2.747M	$2.968M	$4.933M
YoY Change	-37.05%	-39.83%	18.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$196.9M	-$196.6M	-$193.7M
YoY Change	1.07%	1.46%	2.94%
Common Stock	$379.00	$378.00	$978.00
YoY Change	170.71%	-61.35%	32.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.248M	$5.372M	$3.574M
YoY Change
Total Liabilities & Shareholders Equity	$7.995M	$8.340M	$8.507M
YoY Change	15.97%	-1.96%	-34.76%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$330.0K	-$257.1K	-$1.405M
YoY Change	-68.87%	-81.69%	-229.33%
Depreciation, Depletion And Amortization	$20.00K	$20.00K	-$10.00K
YoY Change	0.0%	-300.0%	-133.33%
Cash From Operating Activities	$280.0K	-$520.0K	-$1.740M
YoY Change	-566.67%	-70.11%	-557.89%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$10.00K	-$30.00K
YoY Change	-100.0%	-133.33%	-250.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$10.00K	-$30.00K
YoY Change	-100.0%	-133.33%	-250.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.00K	0.000	0.000
YoY Change	100.0%		-100.0%
NET CHANGE
Cash From Operating Activities	280.0K	-520.0K	-1.740M
Cash From Investing Activities	0.000	10.00K	-30.00K
Cash From Financing Activities	20.00K	0.000	0.000
Net Change In Cash	300.0K	-510.0K	-1.770M
YoY Change	-600.0%	-71.19%	-531.71%
FREE CASH FLOW
Cash From Operating Activities	$280.0K	-$520.0K	-$1.740M
Capital Expenditures	$0.00	$10.00K	-$30.00K
Free Cash Flow	$280.0K	-$530.0K	-$1.710M
YoY Change	-660.0%	-69.01%	-575.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4646932	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	City Area Code CityAreaCode	781
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Type DocumentType	10-Q
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3784657	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	43751	USD
CY2019Q4	nuro	Technology Fees TechnologyFees	450000	USD
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q3	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	68000	USD
CY2020Q3	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	6000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	725658	USD
	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	0	USD
CY2020Q3	nuro	Operating Lease Discount OperatingLeaseDiscount	331627	USD
CY2020Q3	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	dei	Entity File Number EntityFileNumber	001-33351
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
	dei	Local Phone Number LocalPhoneNumber	890-9989
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Trading Symbol TradingSymbol	NURO
CY2019Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	689000	USD
CY2020Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	586000	USD
CY2019Q3	nuro	Collaboration Income CollaborationIncome	0	USD
	nuro	Collaboration Income CollaborationIncome	7116667	USD
CY2020Q3	nuro	Collaboration Income CollaborationIncome	0	USD
	nuro	Collaboration Income CollaborationIncome	0	USD
CY2019Q4	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	189008	USD
CY2020Q3	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	0	USD
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	43751	USD
CY2019	nuro	Facility Relocation Costs FacilityRelocationCosts	100000	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	680000	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	0	USD
CY2020Q3	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	76000	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	280000	USD
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	1174092	USD
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-189008	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-438352	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-103000	USD
	nuro	Increase Decreasein Deferred Collaboration Income IncreaseDecreaseinDeferredCollaborationIncome	-1956522	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	192356	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	298967	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	633146	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1443574	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1011228	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	454000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	291000	USD
CY2019Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	62322	USD
CY2020Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	109896	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	762903	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2693146	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197319698	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	201927426	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44093	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19933	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	120460	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	144047	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	128862	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140269	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	505012	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	601966	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	162435	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	186405	shares
CY2019Q4	us-gaap	Assets Assets	6893686	USD
CY2020Q3	us-gaap	Assets Assets	8340038	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	5430814	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	7290140	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3126206	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4929175	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3186636	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4929175	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3593793	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1802969	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5568243	USD
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1400674	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3784657	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1400674	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3784657	shares
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	140	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	378	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	914322	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6382340	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	537614	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1652890	USD
	us-gaap	Depreciation Depreciation	98166	USD
	us-gaap	Depreciation Depreciation	67772	USD
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.06
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8340038	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3446778	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	136569	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3M18D
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1510309	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	653164	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	117431	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1462887	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165785	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	720209	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	1173679	USD
	us-gaap	Gross Profit GrossProfit	1183279	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	690643	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	1498614	USD
	us-gaap	Gross Profit GrossProfit	3915353	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-659538	USD
	us-gaap	Inventory Write Down InventoryWriteDown	2595884	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	166025	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165785	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	498073	USD
CY2020Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	166905	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	247347	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	160797	USD
CY2019Q4	us-gaap	Liabilities Liabilities	4363452	USD
CY2020Q3	us-gaap	Liabilities Liabilities	2968266	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6893686	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-533302	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-558968	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	334179	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	115752	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-694668	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	357673	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-113421	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-189092	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23621	USD
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	443505	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	359650	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1163714	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	1050293	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	500713	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2386363	USD
CY2020Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2020-04-30
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7497	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4151037	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41177	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3560113	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2348068	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	2050507	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-3362191	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1404600	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2716284	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-851944	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-257113	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1766428	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7464	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7159464	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	774	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2323	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	2585743	USD
	us-gaap	Operating Expenses OperatingExpenses	11059027	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	1756501	USD
	us-gaap	Operating Expenses OperatingExpenses	5684104	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1412064	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9875748	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-257887	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1768751	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	588546	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	596779	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	916674	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	581903	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1159774	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	815558	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	333952	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	92132	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	7464	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	42797	USD
CY2020Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	774	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2323	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41177	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	652919	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	677526	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29650	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	28664	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	773200	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7497	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4151037	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	75300	USD
CY2020Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	62200	USD
	us-gaap	Profit Loss ProfitLoss	-2716284	USD
	us-gaap	Profit Loss ProfitLoss	-1766428	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273448	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	205676	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	773200	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	475137	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2365139	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	652671	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1846569	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	2500000	USD
CY2020Q3	us-gaap	Restructuring Reserve RestructuringReserve	400000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194789605	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196600000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196556033	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2088001	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7565619	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2036228	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	647719	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4046956	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	340927	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1144389	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	224773	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	184486	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	413178	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7497	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7606	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453457	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3689974	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43751	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	8192411	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4857650	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	3573510	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2514118	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	5488616	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	5371772	USD
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	true
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	978175	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	886609	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3784657	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2755903	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	978175	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	886609	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3784657	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2755903	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-20-014684-index-headers.html	Edgar Link	pending
0001628280-20-014684-index.html	Edgar Link	pending
0001628280-20-014684.txt	Edgar Link	pending
0001628280-20-014684-xbrl.zip	Edgar Link	pending
a10q9302020document.htm	Edgar Link	pending
a10q9302020ex311.htm	Edgar Link	pending
a10q9302020ex312.htm	Edgar Link	pending
a10q9302020ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20200930.xml	Edgar Link	completed
nuro-20200930.xsd	Edgar Link	pending
nuro-20200930_cal.xml	Edgar Link	unprocessable
nuro-20200930_def.xml	Edgar Link	unprocessable
nuro-20200930_lab.xml	Edgar Link	unprocessable
nuro-20200930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2020 Q4 Form 10-Q Financial Statement

#000162828020014684 Filed on October 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2020 Q4 Form 10-Q Financial Statement

#000162828020014684 Filed on October 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro